Sharlene Day

Sharlene Day

University of Pennsylvania

H-index: 47

North America-United States

About Sharlene Day

Sharlene Day, With an exceptional h-index of 47 and a recent h-index of 40 (since 2020), a distinguished researcher at University of Pennsylvania, specializes in the field of Hypertrophic cardiomyopathy, cardiovascular genetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

A rare splice-site variant in cardiac troponin-T (TNNT2): The need for ancestral diversity in genomic reference datasets

PREDICTORS OF ADVERSE LONG-TERM OUTCOME AFTER SEPTAL REDUCTION THERAPIES IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM THE SHARE REGISTRY

Precision Medicine for Hypertensive Disorders of Pregnancy—Are We There Yet?

10 Pre-clinical studies of sotagliflozin in hypertrophic cardiomyopathy

What’s VAT All About—The Clue Is in the Genetics

Sex-Specific Effect of MTSS1 Downregulation on Dilated Cardiomyopathy

Complex Genetic Architecture of Spontaneous Coronary Artery Dissection

Sports Participation by Athletes With Cardiovascular Disease

Sharlene Day Information

University

Position

___

Citations(all)

8703

Citations(since 2020)

6049

Cited By

4031

hIndex(all)

47

hIndex(since 2020)

40

i10Index(all)

99

i10Index(since 2020)

88

Email

University Profile Page

University of Pennsylvania

Google Scholar

View Google Scholar Profile

Sharlene Day Skills & Research Interests

Hypertrophic cardiomyopathy

cardiovascular genetics

Top articles of Sharlene Day

Title

Journal

Author(s)

Publication Date

A rare splice-site variant in cardiac troponin-T (TNNT2): The need for ancestral diversity in genomic reference datasets

medRxiv

Alexandra Butters

Kate Thomson

Franki Harrington

Natasha Henden

Karen McGuire

...

2024/2/11

PREDICTORS OF ADVERSE LONG-TERM OUTCOME AFTER SEPTAL REDUCTION THERAPIES IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM THE SHARE REGISTRY

Journal of the American College of Cardiology

Niccolo’ Maurizi

Panagiotis Antiochos

Anjali Tiku Owens

Neal K Lakdawala

Sara Saberi

...

2024/4/2

Precision Medicine for Hypertensive Disorders of Pregnancy—Are We There Yet?

Sadiya S Khan

Sharlene M Day

2024/1/3

10 Pre-clinical studies of sotagliflozin in hypertrophic cardiomyopathy

Journal of Clinical and Translational Science

Rebecca Taichman

Benjamin Lee

Kenneth Margulies

Sharlene Day

2024/4

What’s VAT All About—The Clue Is in the Genetics

JAMA cardiology

Sharlene M Day

2024/3/13

Sex-Specific Effect of MTSS1 Downregulation on Dilated Cardiomyopathy

medRxiv

Dongwook Choe

Megan Burke

Jeffrey A Brandimarto

Ingrid Marti-Pamies

Jaime Yob

...

2024

Complex Genetic Architecture of Spontaneous Coronary Artery Dissection

JAMA cardiology

Pradeep Natarajan

Sharlene M Day

2024/3/13

Sports Participation by Athletes With Cardiovascular Disease

Journal of the American College of Cardiology

Matthew W Martinez

Michael J Ackerman

George J Annas

Aaron L Baggish

Sharlene M Day

...

2024/2/27

Early or late-life treatment with acarbose or rapamycin improves physical performance and affects cardiac structure in aging mice

The Journals of Gerontology: Series A

Jonathan J Herrera

Kaitlyn Pifer

Sean Louzon

Danielle Leander

Oliver Fiehn

...

2023/3/1

Identifying the role of HSP70 co-chaperones in modulating sarcomeric proteostasis

Graham Branscom

Marcus Wagner

Sharlene Day

2023/5/23

Left ventricular systolic dysfunction in patients diagnosed with hypertrophic cardiomyopathy during childhood: insights from the SHaRe registry

Circulation

Sarah Abou Alaiwi

Thomas M Roston

Peter Marstrand

Brian Lee Claggett

Victoria N Parikh

...

2023/8/1

Patient-reported outcomes in clinical studies of patients with hypertrophic cardiomyopathy

Progress in Cardiovascular Diseases

Nosheen Reza

Sharlene M Day

Anjali Tiku Owens

2023/9/1

Long term outcome after septal reduction therapies in patients with hypertrophic cardiomyopathy: insights from the SHaRe registry

European Heart Journal

N Maurizi

S Day

E Ashley

M Michels

AC Pereira

...

2023/11

Sex-Specific Clinical and Genetic Factors Associated with Adverse Outcomes in Hypertrophic Cardiomyopathy

medRxiv

Alexandra Butters

Clare Arnott

Joanna Sweeting

Brian Claggett

Anna Cuomo

...

2023

Transforming Growth Factor-β Analysis of the VANISH Trial Cohort

Circulation: Heart Failure

Yuri Kim

Mitra Mastali

Jennifer E Van Eyk

E John Orav

Christoffer R Vissing

...

2023/4

Common-and rare-variant genetic architecture of heart failure across the allele frequency spectrum

medRxiv

David SM Lee

Katie M Cardone

David Y Zhang

Sarah Abramowitz

John S DePaolo

...

2023/7/19

An unbiased screen identified the Hsp70-BAG3 complex as a regulator of myosin-binding protein C3

Basic to Translational Science

Andrea D Thompson

Marcus J Wagner

Juliani Rodriguez

Alok Malhotra

Steve Vander Roest

...

2023/9/1

Perfomance of sudden cardiac death prediction strategies before and after Septal Reduction Strategies in patients with Hypertrophic Cardiomyopathy

European Heart Journal

N Maurizi

C Fumagalli

C Ho

S Day

I Olivotto

2023/11

Update on Cardiac Myosin Inhibitors and Potential Role in Treating Obstructive Hypertrophic Cardiomyopathy

Michael J Litt

Sharlene M Day

2023/1

Leisure-time and competitive sport participation: a changing paradigm for HCM patients

Antonio Pelliccia

Sharlene Day

Iacopo Olivotto

2023/4/1

See List of Professors in Sharlene Day University(University of Pennsylvania)